Device
SPECT imaging
SPECT imaging is a medical device with 4 clinical trials. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Terminated(1)
Other(2)
Detailed Status
unknown2
Completed1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (50.0%)
N/A1 (50.0%)
Trials by Status
completed125%
terminated125%
unknown250%
Recent Activity
0 active trials
Showing 4 of 4
terminatednot_applicable
Simultaneous Assessment of FFR and SPECT
NCT02749045
completed
Rubidium-82 Position Emission Computed Tomography (PET) Versus Gated, Rest / Stress Technetium 99-m SPECT
NCT01179230
unknownphase_2
124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.
NCT01931488
unknown
Stress Adenosine Cardiac Magnetic Resonance (MR) Comparison With Single Photon Emission Computed Tomography (SPECT) Imaging
NCT00864591
Clinical Trials (4)
Showing 4 of 4 trials
NCT02749045Not Applicable
Simultaneous Assessment of FFR and SPECT
NCT01179230
Rubidium-82 Position Emission Computed Tomography (PET) Versus Gated, Rest / Stress Technetium 99-m SPECT
NCT01931488Phase 2
124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.
NCT00864591
Stress Adenosine Cardiac Magnetic Resonance (MR) Comparison With Single Photon Emission Computed Tomography (SPECT) Imaging
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4